These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 26392499

  • 21. Activity of posaconazole in treatment of experimental disseminated zygomycosis.
    Dannaoui E, Meis JF, Loebenberg D, Verweij PE.
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3647-50. PubMed ID: 14576138
    [Abstract] [Full Text] [Related]

  • 22. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, Rinaldi M, Fothergill A, Gibbs DL, Wang A.
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [Abstract] [Full Text] [Related]

  • 23. Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes.
    Gil-Lamaignere C, Hess R, Salvenmoser S, Heyn K, Kappe R, Müller FM.
    J Antimicrob Chemother; 2005 Jun; 55(6):1016-9. PubMed ID: 15883179
    [Abstract] [Full Text] [Related]

  • 24. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 25. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
    Maurer E, Hörtnagl C, Lackner M, Grässle D, Naschberger V, Moser P, Segal E, Semis M, Lass-Flörl C, Binder U.
    Med Mycol; 2019 Apr 01; 57(3):351-362. PubMed ID: 29924357
    [Abstract] [Full Text] [Related]

  • 26. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC, Chen YH, Chen YC, Lu PL.
    Kaohsiung J Med Sci; 2012 Jun 01; 28(6):306-15. PubMed ID: 22632885
    [Abstract] [Full Text] [Related]

  • 27. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.
    Bellanger AP, Tatara AM, Shirazi F, Gebremariam T, Albert ND, Lewis RE, Ibrahim AS, Kontoyiannis DP.
    J Infect Dis; 2016 Jul 01; 214(1):114-21. PubMed ID: 26984141
    [Abstract] [Full Text] [Related]

  • 28. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
    Simitsopoulou M, Roilides E, Maloukou A, Gil-Lamaignere C, Walsh TJ.
    Mycoses; 2008 Mar 01; 51(2):147-54. PubMed ID: 18254752
    [Abstract] [Full Text] [Related]

  • 29. Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
    Aller AI, Claro R, Castro C, Serrano C, Colom MF, Martín-Mazuelos E.
    Chemotherapy; 2007 Mar 01; 53(4):300-5. PubMed ID: 17496416
    [Abstract] [Full Text] [Related]

  • 30. Triazole antifungal agents in invasive fungal infections: a comparative review.
    Lass-Flörl C.
    Drugs; 2011 Dec 24; 71(18):2405-19. PubMed ID: 22141384
    [Abstract] [Full Text] [Related]

  • 31. Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
    Kantarcioğlu AS, Boekhout T, Yücel A, Altas K.
    Med Mycol; 2009 Mar 24; 47(2):169-76. PubMed ID: 18654925
    [Abstract] [Full Text] [Related]

  • 32. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Skóra M, Bulanda M, Jagielski T.
    Antimicrob Agents Chemother; 2015 Sep 24; 59(9):5827-9. PubMed ID: 26100698
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
    Chowdhary A, Singh PK, Kathuria S, Hagen F, Meis JF.
    Antimicrob Agents Chemother; 2015 Dec 24; 59(12):7882-7. PubMed ID: 26438489
    [Abstract] [Full Text] [Related]

  • 34. Rhizopus Infection in a Preterm Infant: A Novel Use of Posaconazole.
    Fatemizadeh R, Rodman E, Demmler-Harrison GJ, Dinu D.
    Pediatr Infect Dis J; 2020 Apr 24; 39(4):310-312. PubMed ID: 32084112
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of voriconazole against selected fungi.
    McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR, Rinaldi MG.
    Med Mycol; 1998 Aug 24; 36(4):239-42. PubMed ID: 9776841
    [Abstract] [Full Text] [Related]

  • 36. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
    Ville S, Talarmin JP, Gaultier-Lintia A, Bouquié R, Sagan C, Le Pape P, Giral M, Morio F.
    Exp Clin Transplant; 2016 Feb 24; 14(1):96-9. PubMed ID: 25275881
    [Abstract] [Full Text] [Related]

  • 37. Effects of Photodynamic Inactivation on the Growth and Antifungal Susceptibility of Rhizopus oryzae.
    Liu Z, Tang J, Sun Y, Gao L.
    Mycopathologia; 2019 Apr 24; 184(2):315-319. PubMed ID: 30689142
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.
    Gebremariam T, Alkhazraji S, Lin L, Wiederhold NP, Garvey EP, Hoekstra WJ, Schotzinger RJ, Patterson TF, Filler SG, Ibrahim AS.
    Antimicrob Agents Chemother; 2017 Sep 24; 61(9):. PubMed ID: 28652241
    [Abstract] [Full Text] [Related]

  • 39. Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
    Gebremariam T, Alkhazraji S, Baldin C, Kovanda L, Wiederhold NP, Ibrahim AS.
    Antimicrob Agents Chemother; 2017 May 24; 61(5):. PubMed ID: 28264840
    [Abstract] [Full Text] [Related]

  • 40. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection.
    Ben-Ami R, Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DP.
    Antimicrob Agents Chemother; 2010 Jan 24; 54(1):484-90. PubMed ID: 19858263
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.